14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.28 $2.66 Wednesday, 1st May 2024 CNTB stock ended at $1.43. This is 2.88% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 10.53% from a day low at $1.33 to a day high of $1.47.
90 days $0.90 $2.66
52 weeks $0.550 $2.84

Historical Connect Biopharma Holdings Limited American Depositary Shares prices

Date Open High Low Close Volume
May 07, 2021 $16.45 $16.80 $15.52 $15.53 41 103
May 06, 2021 $16.80 $16.80 $15.94 $16.10 8 955
May 05, 2021 $16.19 $16.97 $15.57 $16.82 38 932
May 04, 2021 $15.80 $16.30 $15.80 $16.16 23 699
May 03, 2021 $16.53 $16.62 $16.04 $16.31 8 468
Apr 30, 2021 $15.51 $16.76 $15.51 $16.27 37 060
Apr 29, 2021 $15.76 $16.71 $15.54 $15.54 53 428
Apr 28, 2021 $16.35 $16.35 $15.52 $16.05 32 626
Apr 27, 2021 $15.81 $16.81 $15.55 $16.07 90 100
Apr 26, 2021 $16.74 $17.00 $15.51 $16.53 78 638
Apr 23, 2021 $16.80 $17.03 $16.01 $16.12 208 704
Apr 22, 2021 $17.36 $17.36 $16.91 $17.11 6 662
Apr 21, 2021 $16.96 $17.87 $16.83 $17.09 79 090
Apr 20, 2021 $17.03 $17.61 $16.80 $17.08 152 142
Apr 19, 2021 $16.80 $17.88 $16.80 $17.24 388 675
Apr 16, 2021 $16.54 $17.40 $16.53 $17.27 46 300
Apr 15, 2021 $17.45 $17.58 $16.50 $17.30 130 085
Apr 14, 2021 $16.89 $18.73 $16.34 $17.45 247 998
Apr 13, 2021 $17.09 $17.75 $16.32 $16.95 150 668
Apr 12, 2021 $16.52 $17.15 $16.23 $17.05 56 758
Apr 09, 2021 $16.52 $17.15 $16.22 $17.00 12 718
Apr 08, 2021 $17.30 $17.40 $16.18 $16.40 72 103
Apr 07, 2021 $17.49 $17.99 $16.67 $17.07 74 412
Apr 06, 2021 $17.75 $19.69 $16.77 $17.51 361 461
Apr 05, 2021 $17.69 $18.50 $17.13 $17.90 141 589
Click to get the best stock tips daily for free!

About Connect Biopharma Holdings Limited American Depositary Shares

Connect Biopharma Holdings Limited American Depositary Shares Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosin... CNTB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT